Dr. Kartick Rastogi

   MBBS, MD (Radiation Oncology)

Book An Appointment

Home / Doctors / Dr. Kartick Rastogi

Dr. Kartick Rastogi

Consultant – Radiation Oncology


MBBS, MD (Radiation Oncology)


Radiation Oncology


HCG Cancer Centre - Jaipur


8 Years

  • Dr. Kartick Rastogi is a highly skilled and experienced consultant – radiation oncology practising at HCG Cancer Centre, Jaipur. 
  • He has over 8 years of experience in the radiation management of a broad spectrum of cancers. 
  • Dr. Kartick is an expert at administering radiation therapy through the following approaches:
    • Linear Accelerator: Varian Trilogy FFF Linear Accelerator, Varian Clinac iX 2300CD Linear Accelerator, Elekta Synergy Linear Accelerator, Siemens Oncor Expression Linear Accelerator
    • Brachytherapy: Eckert & Ziegler BEBIG Cobalt Brachytherapy, Varian GammaMedplus iX Iridium Brachytherapy, microSelectron (Elekta) Iridium Brachytherapy
    • Cobalt Teletherapy: Bhabhatron-II TeleCobalt Machine, ATC-C9 Telecobalt Machine
  • Dr. Kartick is a member of multiple reputed associations like Atomic Energy Regulatory Board (AERB), Gujarat Medical Council (GMC), Rajasthan Medical Council (RMC), European Society of Medical Oncology (ESMO), and Association of Radiation Oncologists of India (AROI).
  • He has presented multiple papers and posters at numerous national conferences.
  • Dr. Kartick’s expertise is recognised with numerous accolades:
    • Travel Grant, ESMO Preceptorship Course on Breast Cancer, 25th - 26th November 2019, Singapore
    • Travel Grant, ESMO Preceptorship Course on Gastrointestinal Tumours, 20th -22nd November 2018, Singapore
    • Best Paper Award (Gold Medal) at State Level, RAJ AROICON 2017, 25th - 26th March 2017, Jaipur (Rajasthan), India.
  • Dosimetric comparison of IMRT versus 3DCRT for post mastectomy chest wall irradiation. Radiat Oncol J 2018;36:71-8. (PMID: 29621872, PMCID: PMC5903359) (38 Citations)
  • A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients. Asia Pac J OncolNurs 2018;5:107-13. (PMID: 29379842, PMCID: PMC5763427) (22 Citations)
  • Palliation of brain metastases: Analysis of prognostic factors affecting overall survival. Indian J Palliat Care 2018;24:308-12. (PMID: 30111944, PMCID: PMC6069611) (19 Citations)
  • Breast cancer‑related lymphedema in postmastectomy patients receiving adjuvant irradiation: A prospective study. Indian J Cancer 2018;55:184-9. (PMID: 30604734) (6 Citation)
  • Symptom palliation in patients with bone metastases treated with radiotherapy. Indian J Med Paediatr Oncol 2019;40:265-9. (PMID: awaited, PMCID: awaited)
  • Depression in cancer patients: Magnitude of problem and factors responsible. Indian J Med Paediatr Oncol 2019;40:542-6. (PMID: awaited, PMCID: awaited)
  • Primary rectal lymphoma with synchronous liver involvement: An extremely rare case report. Indian J Med Paediatr Oncol 2020;41:93-5. (PMID: awaited, PMCID: awaited)
  • Nasal cavity cancer with distal phalanx metastasis: An extremely rare case report. Indian J Med Paediatr Oncol 2019;40:s117-9. (PMID: awaited, PMCID: awaited)
  • Association of Treatment Outcome of Tuberculosis with type of Category of Tuberculosis. International Multispecialty Journal of Health 2015;1:6-9.
  • Compliance to radiotherapy: A tertiary care centre experience. Indian J Cancer 2018;55:166-9. (PMID: 30604730) (17 Citations)
  • A study of hormone receptor status in breast carcinoma and use of HER2 targeted therapy in a tertiary care centre of India. Indian J Med Paediatr Oncol 2019;40:s54-60. (PMID: awaited, PMCID: awaited) (2 Citation)
  • Tumour bleeding: Efficacy and outcome of haemostatic radiotherapy. Natl Med J India 2019;32:342-4. (PMID 33380626)
  • Compliance, Toxicity & Survival function analysis of Locoregionally Advanced Squamous Cell Carcinoma of Head and Neck treated with definitive Radiotherapy Concurrent with weekly Cisplatin. J Biol Engg Res & Rev 2017; 4:7-12.
  • A Comparative Study of Weekly Cetuximab Versus Cisplatin With Concurrent Radiotherapy in Elderly Patients of Locoregionally Advanced Squamous Cell Carcinoma of Head And Neck. International Journal of Current Advanced Research 2018:7;10160-4.
  • Changing Trends in Epidemiology, Diagnosis, and Management of breast Cancer in north-west India over a Decade. International Journal of Current Advanced Research 2019;8:17524-8.
  • Bhaskar S, Rastogi K*, Gupta S, Jindal A. Primary neuroendocrine carcinoma of kidney: A rare case report. Indian J Med Paediatr Oncol 2020;41:264-5. (PMID: awaited, PMCID: awaited) (1 Citation)
  • Weekly versus tri-weekly cisplatin concurrent with radiotherapy in the treatment of locally advanced carcinoma cervix: A prospective study. Indian J Med Paediatr Oncol 2018;39:467-72. (PMID: awaited, PMCID: awaited)
  • Hypofractionated radiotherapy for palliation in locally advanced head and neck cancer. Indian J Palliat Care 2017;23:313-6. (PMID: 28827937, PMCID: 5545959) (6 Citations)
  • A comparative study of toxicities during treatment with IMRT versus 3DCRT in locoregionally advanced head and neck carcinoma. IOSR Journal of Dental and Medical Sciences 2017;16:66-69.
  • Reirradiation in patients with recurrent head-and-neck carcinoma. J Med Soc 2018;32:185-9. (1 Citation)
  • A prospective comparative study of concurrent versus sequential intracavitary brachytherapy with external beam radiotherapy in cervical cancer. International Journal of Current Advanced Research 2020:9;22189-92.
  • Hypofractionated accelerated radiotherapy compared with conventional radiotherapy of squamous cell carcinoma of head and neck with concurrent cisplatin. IOSR Journal of Dental and Medical Sciences 2017;16:80-3.
  • The role of ultrasound-guided applicator placement in intracavitary brachytherapy for cervical cancer. J Med Soc 2018;32:7-11. (1 Citation)

   Practices at

Other Doctors